251 related articles for article (PubMed ID: 28002629)
21. Phenotypic and functional heterogeneity of CD169⁺ and CD163⁺ macrophages from porcine lymph nodes and spleen.
Alvarez B; Martínez P; Yuste M; Poderoso T; Alonso F; Domínguez J; Ezquerra A; Revilla C
Dev Comp Immunol; 2014 May; 44(1):44-9. PubMed ID: 24291017
[TBL] [Abstract][Full Text] [Related]
22. Loss of CD169
Topf MC; Harshyne L; Tuluc M; Mardekian S; Vimawala S; Cognetti DM; Curry JM; Rodeck U; Luginbuhl A
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):67-73. PubMed ID: 30744470
[TBL] [Abstract][Full Text] [Related]
23. Sialoglycans on lymphatic endothelial cells augment interactions with Siglec-1 (CD169) of lymph node macrophages.
D'Addio M; Frey J; Tacconi C; Commerford CD; Halin C; Detmar M; Cummings RD; Otto VI
FASEB J; 2021 Nov; 35(11):e22017. PubMed ID: 34699642
[TBL] [Abstract][Full Text] [Related]
24. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
[TBL] [Abstract][Full Text] [Related]
25. CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer.
Kumamoto K; Tasaki T; Ohnishi K; Shibata M; Shimajiri S; Harada M; Komohara Y; Nakayama T
Front Oncol; 2021; 11():636751. PubMed ID: 33816277
[TBL] [Abstract][Full Text] [Related]
26. SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions.
Pucci F; Garris C; Lai CP; Newton A; Pfirschke C; Engblom C; Alvarez D; Sprachman M; Evavold C; Magnuson A; von Andrian UH; Glatz K; Breakefield XO; Mempel TR; Weissleder R; Pittet MJ
Science; 2016 Apr; 352(6282):242-6. PubMed ID: 26989197
[TBL] [Abstract][Full Text] [Related]
27. Lymph Node Subcapsular Sinus Macrophages as the Frontline of Lymphatic Immune Defense.
Louie DAP; Liao S
Front Immunol; 2019; 10():347. PubMed ID: 30891035
[TBL] [Abstract][Full Text] [Related]
28. CD169
Grabowska J; Lopez-Venegas MA; Affandi AJ; den Haan JMM
Front Immunol; 2018; 9():2472. PubMed ID: 30416504
[TBL] [Abstract][Full Text] [Related]
29. Tumor Necrosis Factor-Mediated Survival of CD169
Shinde PV; Xu HC; Maney SK; Kloetgen A; Namineni S; Zhuang Y; Honke N; Shaabani N; Bellora N; Doerrenberg M; Trilling M; Pozdeev VI; van Rooijen N; Scheu S; Pfeffer K; Crocker PR; Tanaka M; Duggimpudi S; Knolle P; Heikenwalder M; Ruland J; Mak TW; Brenner D; Pandyra AA; Hoell JI; Borkhardt A; Häussinger D; Lang KS; Lang PA
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142134
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
31. Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer.
Takeya H; Ohnishi K; Shiota T; Saito Y; Fujiwara Y; Yagi T; Kiyozumi Y; Baba Y; Yoshida N; Asano K; Tanaka M; Baba H; Komohara Y
J Clin Exp Hematop; 2019; 59(3):112-118. PubMed ID: 31564713
[TBL] [Abstract][Full Text] [Related]
32. Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes.
Hood JL
Med Hypotheses; 2016 Sep; 94():118-22. PubMed ID: 27515216
[TBL] [Abstract][Full Text] [Related]
33. CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid.
Asano K; Kikuchi K; Tanaka M
J Biochem; 2018 Aug; 164(2):77-85. PubMed ID: 29905851
[TBL] [Abstract][Full Text] [Related]
34. Targeted Delivery of Antigen to Activated CD169
Edgar LJ; Kawasaki N; Nycholat CM; Paulson JC
Cell Chem Biol; 2019 Jan; 26(1):131-136.e4. PubMed ID: 30393066
[TBL] [Abstract][Full Text] [Related]
35. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
[TBL] [Abstract][Full Text] [Related]
36. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles.
Black LV; Saunderson SC; Coutinho FP; Muhsin-Sharafaldine MR; Damani TT; Dunn AC; McLellan AD
Immunol Cell Biol; 2016 May; 94(5):430-8. PubMed ID: 26647968
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of CD169-positive macrophages in various tumors: a meta-analysis.
Kong W; Wei M; Liu R; Zhang J; Wang X
Bioengineered; 2021 Dec; 12(1):8505-8514. PubMed ID: 34607536
[TBL] [Abstract][Full Text] [Related]
38. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
Messaoudene M; Fregni G; Fourmentraux-Neves E; Chanal J; Maubec E; Mazouz-Dorval S; Couturaud B; Girod A; Sastre-Garau X; Albert S; Guédon C; Deschamps L; Mitilian D; Cremer I; Jacquelot N; Rusakiewicz S; Zitvogel L; Avril MF; Caignard A
Cancer Res; 2014 Jan; 74(1):81-92. PubMed ID: 24225017
[TBL] [Abstract][Full Text] [Related]
39. Research progress on CD169-positive macrophages in tumors.
Hou X; Chen G; Zhao Y
Am J Transl Res; 2021; 13(8):8589-8597. PubMed ID: 34539981
[TBL] [Abstract][Full Text] [Related]
40. Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8
van Dinther D; Veninga H; Iborra S; Borg EGF; Hoogterp L; Olesek K; Beijer MR; Schetters STT; Kalay H; Garcia-Vallejo JJ; Franken KL; Cham LB; Lang KS; van Kooyk Y; Sancho D; Crocker PR; den Haan JMM
Cell Rep; 2018 Feb; 22(6):1484-1495. PubMed ID: 29425504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]